Similarly, the use of mouse models including murine xenograft and immunocompetent allograft models as well as inducible, tissue specific deletion and overexpression of TRIB2 will help to further define the specific role of TRIB2 in the formation, progression and therapy resistance of different tumour types. This evidence concerns the gene TRIB2 and neoplasm.